SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dataminer1 who wrote (333)8/1/1999 9:39:00 AM
From: Thomas Kirwin   of 422
 
R&A Fast Fact #6 - Market Size/Share

"We estimate the potential market for all three instruments at $446.8 million, with an annual reagent trail of $210.5 million. Obtaining even a 10% share of that market would more than double Immucor's current annual volume. We believe the company can achieve that goal over the next two to three years, substantially expanding its base of sales and earnings, and solidifying its competitive position"

Best O'Luck

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News